Centessa Pharmaceuticals Q4 EPS $(0.38) Beats $(0.48) Estimate
Centessa Pharmaceuticals Q4 EPS $(0.38) Beats $(0.48) Estimate
Centessa Pharmicals第四季度每股收益美元（0.38）超過預期（0.48）
Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.48) by 20.83 percent. This is a 15.56 percent increase over losses of $(0.45) per share from the same period last year.
Centessa Pharmicals（納斯達克股票代碼：CNTA）公佈的季度虧損爲每股0.38美元，比分析師普遍預期的0.48美元（0.48美元）高出20.83個百分點。這比去年同期每股虧損0.45美元（0.45美元）增長了15.56％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。